← Back to Clinical Trials
Recruiting NCT06556589

Collaborative Care for Treatment of Depression and Anxiety

Trial Parameters

Condition Depression
Sponsor Kaiser Permanente
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-03-01
Completion 2024-09-30
All Conditions
Interventions
Collaborative Care

Brief Summary

The goal of this project is to evaluate the effectiveness of a collaborative care model for primary care patients at Kaiser Permanente Colorado (KPCO) with depression and/or anxiety. Collaborative care uses evidence-based short-term treatments delivered to patients over the phone. We will explore the use of cost-efficient automated processes for patient outreach and follow-up, such as care pools of patients and using patient portal messaging, risk-based results routing to providers, and electronic health record (EHR) tools for patient tracking and outcome assessment. Using a cluster randomized design, we will compare results between clinics that are offering collaborative care to those that are not.

Eligibility Criteria

Inclusion Criteria: * 18+ * Current membership and active on patient portal * Depression Diagnosis in the prior year * Overdue for PHQ9 Screening based on the following criteria: * High Risk: Last PHQ9 screener was completed greater than 4 months ago AND total Score is greater than or equal 10 or item 9 is greater than 0. * Low Risk: Last PHQ9 screener was completed greater than 12 months ago AND Last PHQ9 Total Score is less than 10 and item 9 is equal to 0. * Anxiety diagnoses in the prior year * Has a baseline GAD7 in the same prior year; score = 10+ (\*Note: Provider referrals could be GAD7 score of 7 or higher) * No Behavioral Health (BH) engagement in the prior year * Patient is not in a Skilled Nursing Facility or Hospice * Patient has no record of psychiatric hospitalization in the last year * Patient does not need an interpreter (i.e., English speaking) * Primary care location is one of the intervention clinics Exclusion Criteria: • Exclude individuals with any of the followin

Related Trials